PRODERMIS at IMCAS Paris 2026: Introducing PROSCULPT™ and the New PRODERMIS Skincare Line
We’re delighted to announce our participation in IMCAS Paris 2026, one of the world’s most prestigious events in dermatology, plastic surgery, and aesthetic science. Taking place at the Palais des Congrès de Paris, this annual congress gathers global leaders, innovators, and practitioners to explore the future of medical aesthetics.
Building on a year of exceptional progress, PRODERMIS returns to present PROSCULPT™, the first cross-linked hyaluronic acid dermal filler with Polynucleotides, and to introduce the PRODERMIS Skincare Line - a new collection developed to complement our injectable portfolio with clinically advanced, regenerative formulations.
Visit Us at Booth D124
Meet the Prodermis team at Booth D124 and discover how our latest innovations are shaping the next generation of aesthetic care. Experience first-hand our complete range of regenerative injectables and professional skincare solutions, and learn how Prodermis is redefining natural results through science-driven design.
Product & Skincare Launch Highlights
PROSCULPT™ – Hybrid Filler Innovation
The first cross-linked dermal filler to combine hyaluronic acid and polynucleotides,
PROSCULPT™ delivers structural lift, tissue regeneration, and natural contour definition for balanced, long-lasting results.
PROSKIN HYDROBOOST – Advanced Regenerative Skin Booster
Combining 82.5 mg of high and low molecular weight hyaluronic acid with polynucleotides, amino acids, and peptides, this next-generation formula delivers intense hydration, improves elasticity, and enhances skin luminosity.
PROEYE ILLUMINATE – Targeted Under Eye Rejuvenation
Formulated with 20 mg of polynucleotides, hyaluronic acid, peptides, and vitamins, it visibly reduces dark circles, puffiness, and fine lines while brightening and revitalising the eye contour.
NEW – PRODERMIS Skincare Line
A professional-grade collection developed with the same scientific precision as our injectables, designed to support skin regeneration, hydration, and radiance at every stage of treatment. Infused with biomimetic peptides, antioxidants, and hyaluronic acid, the new skincare line completes the Prodermis ecosystem - merging clinical performance with daily care.
Plan Your Visit
Dates: Thursday–Saturday, 30 January – 1 February 2026
Venue: Palais des Congrès, Paris, France
Booth: D124
Join us at IMCAS Paris 2026 and be among the first to experience PROSCULPT™, the first Dermal Filler to combine cross-linked Hyaluronic Acid and Polynucleotides.
Category Post

ck.
PRODERMIS PROSCULPT — Redefining the Science of Dermal Fillers
Prodermis Prosculpt is the first hybrid dermal filler to combine cross-linked Hyaluronic Acid with Polynucleotides in a patented formulation. This synergy delivers immediate volumisation and lift alongside progressive dermal regeneration, superior rheology, reduced injection force, and extended longevity of up to 56 weeks — redefining filler performance and clinical outcomes.


